Terns Pharmaceuticals Inc (NAS:TERN)
$ 5.88 -0.13 (-2.16%) Market Cap: 380.30 Mil Enterprise Value: 147.84 Mil PE Ratio: 0 PB Ratio: 1.61 GF Score: 38/100

Terns Pharmaceuticals Inc at Evercore ISI HealthCONx Conference (Virtual) Transcript

Nov 30, 2022 / 08:55PM GMT
Release Date Price: $7.77 (+23.33%)
Liisa Bayko
Evercore Inc. - Analyst

And for a HealthCONx virtual, next year will be in Miami; so, mark your calendars. But we are live from New York, like meaning we're in New York, but we're all on the video cam. I'm really pleased to be here with Terns. Mark and I have known each other for quite a few years and different iterations.

Mark Vignola
Terns Pharmaceuticals, Inc. - CFO

Hundred percent.

Liisa Bayko
Evercore Inc. - Analyst

Yes, and Erin and I are fast becoming good friends and it was nice to see you guys at the Liver Meeting a couple of weeks ago. I'm excited to dig into some questions. I think to start off, why don't we just go for a quick overview of Terns just to orient people who are on the the webinar but maybe a little less familiar?

Erin Quirk
Terns Pharmaceuticals, Inc. - President, Head of Research & Development

Yes. So happy to take that. Liisa, thanks so much for the opportunity to be at the conference today. So Terns is a clinical-stage

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot